140 related articles for article (PubMed ID: 10865197)
21. Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144.
Kubota A; Kubota S; Farrell HE; Davis-Poynter N; Takei F
Cell Immunol; 1999 Feb; 191(2):145-51. PubMed ID: 9973537
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of selective signaling events in natural killer cells recognizing major histocompatibility complex class I.
Kaufman DS; Schoon RA; Robertson MJ; Leibson PJ
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6484-8. PubMed ID: 7604018
[TBL] [Abstract][Full Text] [Related]
23. Histocompatibility antigens and natural killer susceptibility.
Peña J; Solana R
Immunol Res; 1992; 11(2):133-40. PubMed ID: 1431422
[TBL] [Abstract][Full Text] [Related]
24. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity.
Liao NS; Bix M; Zijlstra M; Jaenisch R; Raulet D
Science; 1991 Jul; 253(5016):199-202. PubMed ID: 1853205
[TBL] [Abstract][Full Text] [Related]
25. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
[TBL] [Abstract][Full Text] [Related]
26. Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers.
Cosman D; Fanger N; Borges L
Immunol Rev; 1999 Apr; 168():177-85. PubMed ID: 10399074
[TBL] [Abstract][Full Text] [Related]
27. Human leukocyte antigen E in human cytomegalovirus infection: friend or foe?
Gong F; Song S; Lv G; Pan Y; Zhang D; Jiang H
Acta Biochim Biophys Sin (Shanghai); 2012 Jul; 44(7):551-4. PubMed ID: 22576308
[TBL] [Abstract][Full Text] [Related]
28. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.
Dunn C; Chalupny NJ; Sutherland CL; Dosch S; Sivakumar PV; Johnson DC; Cosman D
J Exp Med; 2003 Jun; 197(11):1427-39. PubMed ID: 12782710
[TBL] [Abstract][Full Text] [Related]
29. Current perspectives of natural killer cell education by MHC class I molecules.
Höglund P; Brodin P
Nat Rev Immunol; 2010 Oct; 10(10):724-34. PubMed ID: 20818413
[TBL] [Abstract][Full Text] [Related]
30. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE
Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836
[TBL] [Abstract][Full Text] [Related]
31. NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation.
Falk CS; Mach M; Schendel DJ; Weiss EH; Hilgert I; Hahn G
J Immunol; 2002 Sep; 169(6):3257-66. PubMed ID: 12218145
[TBL] [Abstract][Full Text] [Related]
32. Viral evasion of natural killer cells.
Orange JS; Fassett MS; Koopman LA; Boyson JE; Strominger JL
Nat Immunol; 2002 Nov; 3(11):1006-12. PubMed ID: 12407408
[TBL] [Abstract][Full Text] [Related]
33. Viral modulation of NK cell immunity.
Lodoen MB; Lanier LL
Nat Rev Microbiol; 2005 Jan; 3(1):59-69. PubMed ID: 15608700
[TBL] [Abstract][Full Text] [Related]
34. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
35. Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells.
Kaufman DS; Schoon RA; Leibson PJ
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8337-41. PubMed ID: 1325654
[TBL] [Abstract][Full Text] [Related]
36. Major histocompatibility complex class I-independent killing of xenogeneic targets by rat allospecific natural killer cells.
Torgersen KM; Salcedo M; Vaage JT; Naper C; Rolstad B; Ljunggren HG; Höglund P
Transplantation; 1997 Jan; 63(1):119-23. PubMed ID: 9000672
[TBL] [Abstract][Full Text] [Related]
37. The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products.
Park B; Oh H; Lee S; Song Y; Shin J; Sung YC; Hwang SY; Ahn K
J Immunol; 2002 Apr; 168(7):3464-9. PubMed ID: 11907106
[TBL] [Abstract][Full Text] [Related]
38. Major histocompatibility complex (MHC) class I recognition by natural killer cells.
Döhring C; Colonna M
Crit Rev Immunol; 1997; 17(3-4):285-99. PubMed ID: 9202884
[TBL] [Abstract][Full Text] [Related]
39. MHC class I receptors on natural killer cells: on with the old and in with the new.
Khakoo SI; Brooks CR
Clin Sci (Lond); 2003 Aug; 105(2):127-40. PubMed ID: 12737620
[TBL] [Abstract][Full Text] [Related]
40. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis.
Ulbrecht M; Martinozzi S; Grzeschik M; Hengel H; Ellwart JW; Pla M; Weiss EH
J Immunol; 2000 May; 164(10):5019-22. PubMed ID: 10799855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
